--:--:--

Sigachi Industries Limited

Web: sigachi.com NSE: SIGACHI BSE: 543389 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

26 0(-2%)

Volume

2c as on 18, Sep

Open

52

High

52

Low

52

Close

27

VWAP

30

52 Week High

41

52 Week Low

17

Viand Research Rating
Quality Score

15/100

Growth Score

25/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

1,003

No. of Shares

38.2

P/E

31.8

P/B

4.15

Face Value

1

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

13.04

ROCE

-

Profit Growth

-

Listing Date

15-Nov-21

Rank/Sector Rank

#1533/#122

Promoter Holding

36.69%

FII Holding

1.25%

DII Holding

-

Price Chart
Price Performance
1 Week22%
1 Month0%
3 Months35%
6 Months49%
1 Year33%
YTD33%
Moving Average
5 Day SMA32
10 Day SMA34
20 Day SMA33
30 Day SMA30
50 Day SMA27
61 Day SMA26
80 Day SMA25
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 335303335
Resistance 233303233
Resistance 131303131
Pivot Point29292929
Support 128292828
Support 226292726
Support 324282624
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,18,69817450%5%4%4%3755.50.0711509
2DIVISLAB2,43,96691902%0%45%38%6955.502568
3TORNTPHARM1,73,20845542%5%10%28%7255.51.792138
4ZYDUSLIFE1,11,45111170%1%20%12%2055.50.313560
5APOLLOHOSP1,09,27676002%9%4%1%5855.50.92003
6LAURUSLABS1,08,73820121%8%83%124%055.50.48890
7CIPLA1,06,15413142%2%8%19%2255.50.023862
8DRREDDY1,03,87312443%8%1%4%2055.50.24158
9MANKIND94,40122864%1%8%7%4955.50.391938
10AUROPHARMA90,84115792%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Feb 2025Dec 2024Sep 2024Aug 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021
Promoters(0.01) 36.69%(-3.01) 36.69%(-0.81) 39.70%(-3.71) 40.48%(0.01) 44.14%(0.01) 44.14%(-0.61) 44.14%(0.01) 44.71%(-0.71) 44.71%(0.01) 45.43%(0.01) 45.43%(-0.61) 45.43%(-2.41) 46.08%(0.01) 48.49%(0.01) 48.49%(0.01) 48.49%(0.01) 48.49%(0.01) 48.48%(0.01) 48.48%(0.01) 48.48%(0.01) 48.48%
FIIs(-0.11) 1.25%(-2.01) 1.31%(0.21) 3.33%(0.21) 3.10%(2.81) 2.89%(-0.11) 0.08%(0.01) 0.20%(-1.41) 0.16%(0.01) 1.58%(0.01) 1.59%(-0.51) 1.55%(0.31) 2.06%(0.81) 1.76%(0.91) 0.95%(0.01) 0.05%(0.01) 0.09%(0.01) 0.05%(-2.61) 0.08%(2.51) 2.69%(-1.21) 0.23%(0.01) 1.42%
DIIs(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.01%(-2.91) 0.01%(-1.81) 2.92%(0.01) 4.70%
Public62.05%62.01%56.97%56.41%52.97%55.77%55.65%55.12%53.69%52.96%53.01%52.51%52.17%50.56%51.45%51.43%51.46%51.43%48.82%48.37%45.41%
No. of Shareholders188,986194,559194,777205,266151,206160,561158,757156,398152,046144,609137,193137,50697,05379,86284,57486,57693,81097,25795,91598,63886,181
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
Sales121.27121.9117.21110.48128.25128.2139.42124.995.71104.13110.9599.1884.772.4268.85827873665755
Sales Growth % (YoY)-5.4%-4.9%-15.9%-11.6%34%23.1%25.7%25.9%13%43.8%61.2%20.3%8.2%-0.2%5%44.2%42.5%40.3%35.8%-25.5%
Sales Growth % (QoQ)-0.5%4%6.1%-13.9%0%-8%11.6%30.5%-8.1%-6.1%11.9%17.1%17%5.2%-16%5.1%6.8%10.6%15.8%3.6%-
Expenses104.76105.49111.49102.96104.1499.65106.25107.6774.6987.888.3677.7668.3960.2554.84666258534443
Operating Profit16.5116.415.727.5224.1128.5533.1717.2321.0216.3322.5921.4216.3112.1714.01161615131412
OPM %13.6113.464.886.8118.822.2723.7913.821.9615.6820.3621.619.2616.820.35202120192422
Other Income10.21-0.267.15-117.072.192.0214.641.687.241.711.111.631.551.29222100
Interest3.014.333.133.133.313.333.822.13.162.871.841.791.271.411.2100000
Depreciation4.414.574.184.114.724.744.673.223.153.492.822.521.961.981.78211111
Profit before tax10.097.72-1.857.43-100.9922.6726.726.5516.3917.2119.6418.2214.7110.3312.32151715121312
Tax %19.330.78-98.92-41.59-0.0228.6723.2220.8322.2111.8518.0217.0126.0429.2420.29112323222322
Net Profit 8.157.65-0.0110.53-100.9716.1820.5121.0112.7615.1716.115.1210.887.329.8214131210109
Net Profit Growth % (QoQ)6.5%76600%-100.1%110.4%-724%-21.1%-2.4%64.7%-15.9%-5.8%6.5%39%48.6%-25.5%-29.9%7.7%8.3%20%-11.1%-
Net Profit Growth % (YoY)108.1%-52.7%-100%-49.9%-891.3%6.7%27.4%39%17.3%107.2%64%8%-16.3%-39%-1.8%40%44.4%----
TTM Net Profit26.32-82.8-74.27-53.75-43.2770.4669.4565.0459.1557.2749.4243.1442.0244.1448.8249454129190
EPS in Rs0.180.20.010.28-2.630.350.640.650.40.460.50.490.350.240.320.440.420.380.310.431.17
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Sales478488399302250193139129101
Sales Growth %-2.1%22.4%32.1%20.7%29.8%38.6%7.8%28.1%-
Expenses42438832224319715411410389
Operating Profit5410077595339252612
OPM %112019192120182012
Other Income-1102112733543
Interest14128411234
Depreciation181611732221
Profit before tax-889270545238252510
Tax %-62418202221202328
Net Profit -83705744403020197
Net Profit Growth %-218.6%22.8%29.5%10%33.3%50%5.3%171.4%-
EPS in Rs-2.141.821.7401.33.942.656.192.25
Dividend Payout %-556080424
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Cash from Operating Activity427132963012148
Cash from Investing Activity-53-93-161-92-63-11-7-6-4
Cash from Financing Activity28117226108-113-9-5
Net Cash Flow-461524-3751780-1
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Equity Capital383838333331318833
Reserves48447056343839723819787574223
Borrowings139145142137151683521302530
Other Liabilities180198103144113372418142116
Total Liabilities8418518467536943742871331099172
Fixed Assets3253273703612541225338322926
CWIP3116989735104321
Investments00000000000
Other Assets48550846738434221622492746146
Total Assets8418518467536943742871331099172
Delivery

Delivery Data: SIGACHI

#Date
26
50%
39
Value (Cr)Q/T
409
Del
47
Del
12
121-Oct26
4
280583
219-Oct27
3
324602
316-Oct28
2
217491
415-Oct28
3
245562
514-Oct28
4
298512
613-Oct28
3
381592
712-Oct28
3
255391
89-Oct29
3
323401
98-Oct29
4
278482
107-Oct29
5
285422
116-Oct30
16
334274
125-Oct29
5
277342
131-Oct28
6
282423
1430-Sep29
5
296422
1529-Sep29
13
269243
1628-Sep29
5
293492
1725-Sep29
8
309474
1824-Sep30
7
346514
1923-Sep31
9
336363
2022-Sep31
10
272394
2121-Sep31
29
351309
2218-Sep30
50
2943517
2317-Sep29
38
3253212
2416-Sep31
16
323335
2515-Sep32
66
4133523
2611-Sep38
17
280386
2710-Sep38
51
3223016
289-Sep35
12
321486
298-Sep35
22
398347
307-Sep34
9
305484
314-Sep35
32
3323010
323-Sep33
7
311393
332-Sep33
6
253453
341-Sep32
5
322503
3531-Aug33
7
339554
3628-Aug33
9
324464
3727-Aug33
8
290514
3826-Aug34
15
401457
3925-Aug34
54
2833016
4024-Aug30
18
601428
4121-Aug30
9
424525
4220-Aug30
26
4614211
4319-Aug29
11
413526
4418-Aug30
30
3434313
4517-Aug26
4
481713
Daily Market Cap
DateTotal Market CapChangeChg %
21-Oct1,003c17c1.65
19-Oct1,020c44c4.13
17-Oct1,064c00
16-Oct1,064c9c0.87
15-Oct1,055c24c2.23
14-Oct1,079c6c0.53
13-Oct1,085c3c0.25
12-Oct1,082c3c0.25
09-Oct1,085c5c0.49
08-Oct1,090c1c0.11
05-Oct1,089c9c0.84
01-Oct1,098c7c0.66
29-Sep1,106c3c0.28
28-Sep1,102c32c2.83
25-Sep1,135c32c2.72
24-Sep1,166c1c0.10
22-Sep1,165c76L0.07
17-Sep1,166c288c19.82
10-Sep1,454c142c10.84
07-Sep1,312c00
Stock Checklist
Price is above from 52 week high low average: 40%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO
Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Oct26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
Bandhan Mutual Fund20.05%+0.01%0
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0